BCR-ABL translocation in a dog with chronic monocytic leukemia

Veterinary Clinical Pathology

Volumn 40, Issue 1, 2011, Pages 40-47

  Cruz Cardona, Janice A ^a   Milner, Rowan ^b   Alleman, A Rick ^a   Williams, Christina ^c   Vernau, William ^d   Breen, Matthew ^c   Tompkins, Mary ^c  

^a Departments of Physiological Sciences   (United States)

^b University of Florida College of Veterinary Medicine   (United States)

^c NORTH CAROLINA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

FISH; Flow cytometry; Monocytosis; Myeloproliferative disorder

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE MARROW CELL; CASE REPORT; DOG; DOG DISEASE; FEMALE; FLOW CYTOMETRY; GENE TRANSLOCATION; GENETICS; MYELOID LEUKEMIA; PATHOLOGY;

ANIMALS; BONE MARROW CELLS; DOG DISEASES; DOGS; FEMALE; FLOW CYTOMETRY; LEUKEMIA, MYELOID; TRANSLOCATION, GENETIC;

ANIMALIA; CANIS FAMILIARIS;

EID: 79952244126     PISSN: 02756382     EISSN: 1939165X     Source Type: Journal    
DOI: 10.1111/j.1939-165X.2010.00277.x     Document Type: Article

References (28)

1. Davidson MG, Rottman JB, English RV, Lappin MR, Tompkins MB. Feline immunodeficiency virus predisposes cats to acute generalized toxoplasmosis. Am J Pathol. 1993;143:1486-1497.
2. Loken M, Denise A. Normal antigen expression in hematopoiesis, basis for interpreting leukemia phenotypes. In: Stewart C, Nicholson J, eds. Immunophenotyping. New York, NY: Wiley-Liss; 2000:133-160.
3. Weiss D. Flow cytometric evaluation of canine bone marrow based on intractyoplasmic complexity and CD45 antigen expression. Vet Clin Pathol. 2004;33:96-101.
4. Harvey JW. Atlas of Veterinary Hematology. Philadelphia, PA: W.B. Saunders Company; 2001.
5. Rossi G, Gelain ME, Foroni S, Comazzi S. Extreme monocytosis in a dog with chronic monocytic leukaemia. Vet Rec. 2009;165:54-56.
6. Fine DM, Tvedten HW. Chronic granulocytic leukemia in a dog. J Am Vet Med Assoc. 1999;214:1809-1812, 1791.
7. Tarrant JM, Stokol T, Blue JT, McDonough SP, Farrell P. Diagnosis of chronic myelogenous leukemia in a dog using morphologic, cytochemical, and flow cytometric techniques. Vet Clin Pathol. 2001;30:19-24.
8. Leifer CE, Matus RE, Patnaik AK, MacEwen EG. Chronic myelogenous leukemia in the dog. J Am Vet Med Assoc. 1983;183:686-689.
9. Pollet L, Van Hove W, Mattheeuws D. Blastic crisis in chronic myelogenous leukaemia in a dog. J Small Anim Pract. 1978;19:469-475.
10. Thomsen MK, Jensen AL, Skak-Nielsen T, Kristensen F. Enhanced granulocyte function in a case of chronic granulocytic leukemia in a dog. Vet Immunol Immunopathol. 1991;28:143-156.
11. Swerdlow S, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue (IARC WHO Classification of Tumours). 4th ed. Geneva, Switzerland: WHO Press; 2008.
12. Rowley JD. Editorial: the role of cytogenetics in hematology. Blood. 1976;48:1-7.
13. Clarkson BD, Strife A, Wisniewski D, Lambek C, Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997;11:1404-1428.
14. Melo JV. BCR-ABL gene variants. Baillieres Clin Haematol. 1997;10:203-222.
15. Breen M, Modiano JF. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res. 2008;16:145-154.
16. Modiano JF, Breen M. Shared pathogenesis of human and canine tumors- an inextricable link between cancer and evolution. Cancer Therapy. 2008;6:239-246.
17. Breen M, Jouquand S, Renier C, et al. Chromosome-specific single-locus FISH probes allow anchorage of an 1800-marker integrated radiation-hybrid/linkage map of the domestic dog genome to all chromosomes. Genome Res. 2001;11:1784-1795.
18. Breen M, Hitte C, Lorentzen TD, et al. An integrated 4249 marker FISH/RH map of the canine genome. BMC Genomics. 2004;5:65.
19. Vernau W, Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Vet Immunol Immunopathol. 1999;69:145-164.
20. Weiss DJ. Evaluation of proliferative disorders in canine bone marrow by use of flow cytometric scatter plots and monoclonal antibodies. Vet Pathol. 2001;38:512-518.
21. Tarrant JM. The role of flow cytometry in companion animal diagnostic medicine. Vet J. 2005;170:278-288.
22. McManus PM. Classification of myeloid neoplasms: a comparative review. Vet Clin Pathol. 2005;34:189-212.
23. Brunning RD. Classification of acute leukemias. Semin Diagn Pathol. 2003;20:142-153.
24. Faucher JL, Lacronique-Gazaille C, Frebet E, et al. "6 markers/5 colors" extended white blood cell differential by flow cytometry. Cytometry A. 2007;71:934-944.
25. Allison RW, Brunker JD, Breshears MA, et al. Dendritic cell leukemia in a Golden Retriever. Vet Clin Pathol. 2008;37:190-197.
26. Ruslander DA, Gebhard DH, Tompkins MB, Grindem CB, Page RL. Immunophenotypic characterization of canine lymphoproliferative disorders. In Vivo. 1997;11:169-172.
27. Palandri F, Iacobucci I, Martinelli G, et al. Long-term outcome of complete cytogenetic responders after imatinib 400mg in late chronic phase, Philadelphia-positive chronic myeloid leukemia: the GIMEMA working party on CML. J Clin Oncol. 2008;26:106-111.
28. Sawyers CL, Hochhaus A, Feldman E, et al. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. Blood. 2002;99:3530-3539.